Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
31/07/2025
Spot platinum just broke through the $1380.00 per ounce level, currently trading at $1379.45 per ounce, down 0.81% on the day; Nymex platinum futures are currently trading at $1410.2 per ounce, down 0.66% on the day.
Latest
1 m ago
Shenzhen: By the end of 2026, it will have built 10 low-altitude economic industrial parks and 2 characteristic industrial parks, covering technology research and development, production manufacturing, marketing and display formats.
2 m ago
Hong Kong stocks are fluctuating | Wescott Group (00856.HK) rises more than 3% during trading, the company's Southeast Asian business is diversifying its layout. Institutions believe that its current valuation has significant upside potential.
2 m ago
Hong Kong stocks are abnormal | AI concept stocks are strong, and recent AI applications have multiple catalysts. Institutions say that the second half of the year, AI is the main investment opportunity.
2 m ago
Stocks in Hong Kong are moving differently, with Kangfang Biotech (09926.HK) rising nearly 5% to hit a new high. The first dose of the Yivosei joint treatment plan for treating IO-resistant NSCLC in Phase III clinical trials has been completed.
3 m ago
Shenzhen: By the end of 2026, the low-altitude economic headquarters R&D testing overall layout of "1+5+4" will be completed, and the output value scale will exceed 130 billion.
See all latest